» Articles » PMID: 22807044

Maternal Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Risk of Neural Tube Defect-affected Pregnancies

Overview
Publisher Wiley
Date 2012 Jul 19
PMID 22807044
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study evaluated whether there is an association between maternal occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and neural tube defects (NTDs) in offspring. This is the first such study of which the authors are aware.

Methods: Data were analyzed from 1997 to 2002 deliveries in the National Birth Defects Prevention Study, a large population-based case-control study in the United States. Maternal interviews yielded information on jobs held in the month before through 3 months after conception. Three industrial hygienists blinded to case or control status assessed occupational exposure to PAHs. Crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were estimated using unconditional logistic regression.

Results: Of the 520 mothers of children with NTDs, 5.0% were classified as exposed to occupational PAHs, as were 3.5% of the 2989 mothers of controls. The crude OR for PAH exposure was 1.43 (95% CI, 0.92-2.22) for any NTD and 1.71 (95% CI, 1.03-2.83) for spina bifida. Adjusted ORs were smaller in magnitude and not significant. Among women who were normal weight or underweight, the crude OR for spina bifida was 3.13 (95% CI, 1.63-6.03) and adjusted OR was 2.59 (95% CI, 1.32-5.07). Based on estimated cumulative exposure, a statistically significant dose-response trend was observed for spina bifida; however, it was attenuated and no longer significant after adjustment.

Conclusion: Maternal occupational exposure to PAHs may be associated with increased risk of spina bifida in offspring among women who are normal weight or underweight. Other comparisons between PAHs and NTDs were consistent with no association.

Citing Articles

High fat diet-induced obesity and gestational DMBA exposure alter folliculogenesis and the proteome of the maternal ovary†.

Novbatova G, Fox I, Timme K, Keating A Biol Reprod. 2024; 111(2):496-511.

PMID: 38813940 PMC: 11327317. DOI: 10.1093/biolre/ioae070.


Disparities in Toxic Chemical Exposures and Associated Neurodevelopmental Outcomes: A Scoping Review and Systematic Evidence Map of the Epidemiological Literature.

Payne-Sturges D, Taiwo T, Ellickson K, Mullen H, Tchangalova N, Anderko L Environ Health Perspect. 2023; 131(9):96001.

PMID: 37754677 PMC: 10525348. DOI: 10.1289/EHP11750.


Distinct H3K27me3 and H3K27ac Modifications in Neural Tube Defects Induced by Benzo[a]pyrene.

Lin S, Wang C, Li Z, Qiu X Brain Sci. 2023; 13(2).

PMID: 36831877 PMC: 9954656. DOI: 10.3390/brainsci13020334.


Birth defects associated with paternal firefighting in the National Birth Defects Prevention Study.

Siegel M, Rocheleau C, Hollerbach B, Omari A, Jahnke S, Almli L Am J Ind Med. 2022; 66(1):30-40.

PMID: 36345775 PMC: 9969860. DOI: 10.1002/ajim.23441.


Overview of Neural Tube Defects: Gene-Environment Interactions, Preventative Approaches and Future Perspectives.

Isakovic J, Simunic I, Jagecic D, Hribljan V, Mitrecic D Biomedicines. 2022; 10(5).

PMID: 35625701 PMC: 9138472. DOI: 10.3390/biomedicines10050965.


References
1.
Yang H, NAMKUNG M, Greenaway J, Fantel A, Juchau M . Mutagenic, cytotoxic, and teratogenic effects of 2-acetylaminofluorene and reactive metabolites in vitro. Teratog Carcinog Mutagen. 1984; 4(3):273-83. DOI: 10.1002/tcm.1770040303. View

2.
Wassenberg D, Nerlinger A, Battle L, Di Giulio R . Effects of the polycyclic aromatic hydrocarbon heterocycles, carbazole and dibenzothiophene, on in vivo and in vitro CYP1A activity and polycyclic aromatic hydrocarbon-derived embryonic deformities. Environ Toxicol Chem. 2005; 24(10):2526-32. DOI: 10.1897/04-440r1.1. View

3.
Barbieri O, Ognio E, Rossi O, Astigiano S, Rossi L . Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives in Swiss mice. Cancer Res. 1986; 46(1):94-8. View

4.
Yoon P, Rasmussen S, Lynberg M, Moore C, Anderka M, Carmichael S . The National Birth Defects Prevention Study. Public Health Rep. 2002; 116 Suppl 1:32-40. PMC: 1913684. DOI: 10.1093/phr/116.S1.32. View

5.
Shimada T . Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 2006; 21(4):257-76. DOI: 10.2133/dmpk.21.257. View